||| Menü 
Startseite
Firmenveranstaltungen, Neuemissionen

10/11
09/11
08/11
07/09
08/09
09/09
10/09
11/09
12/09
01/10
02/10
03/10
Geschäftsberichte, Werbung, Earnings, Marketing, Verordnungen

10/11
09/11
03/09
04/09
05/09
06/09
08/09
09/09
10/09
11/09
12/09
01/10
02/10
Fusionen, Übernahmen

11/11
12/08
01/09
02/09
03/09
04/09
05/09
06/09
07/09
08/09
09/09
10/09
11/09
Personal, Belegschaft, Meldungen zu Produkten

06/08
07/08
08/08
09/08
10/08
11/08
12/08
01/09
02/09
03/09
04/09
05/09
06/09
07/09
08/09

Kontakt
Impressum
Bankleitzahlen - online.de


SGS 2008 Year End Results

Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------




With constant currency revenue growth of 17.7% (10.2% reported basis)
to CHF 4.8 billion, the SGS Group achieved a seventh consecutive year
of improved performance delivering a 13.9% increase in operating
income (pre-exceptional items) to CHF 810 million at an operating
margin of 16.8%.

In an increasingly volatile trading environment, the Group increased
net profit to CHF 579 million (pre-exceptionals), an increase of
12.4% from the prior year. In addition, the Group recorded an
exceptional after tax gain in the Governments & Institutions Services
business of CHF 113 million which has brought net income to CHF 692
million, 38.4% higher than 2007. The Board of Directors has
authorized another share buy-back program of up to CHF 250 million.

Confident about the Group's prospects, having CHF 574 million of cash
on hand at the end of 2008 and having recorded a CHF 15 per share
exceptional gain, the Board of Directors proposes a dividend of CHF
50 per share.



--- End of Message ---

SGS
1 place des Alpes
P.O. Box 2152 Geneva 1 Switzerland

WKN:
870264; ISIN: CH0002497458; Index: SMCI, SMI, SMIEXP, SPI;
Listed: Main Market in SWX Swiss Exchange;
Copyright © Hugin AS 2009. All rights reserved.



 
 ||| Themen-Infos 
· Mehr zu dem Thema Earnings & Marketing, Litigation & regul

Der meistgelesene Artikel zu dem Thema Earnings & Marketing, Litigation & regul:
Carl Zeiss Meditec closes financial year on a high

 ||| Artikel Bewertung 
durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht



Web site engine's code is Copyright © 2003 by PHP-Nuke. All Rights Reserved. PHP-Nuke is Free Software released under the GNU/GPL license.
Erstellung der Seite: 0.086 Sekunden